Centrus Diagnostics, Inc.

Centrus Diagnostics is a pre-Series A medtech company redefining how hypertension and cardiovascular disease are measured and managed. The company has completed a 364-subject FDA-standard rehearsal clinical trial validating its cuffless blood pressure technology and confirming a clear U.S. FDA 510(k) pathway. Centrus is now raising capital to complete FDA testing, pursue near-term licensing opportunities, and expand its AI-driven diagnostic platform for global markets.